Navigation Links
Congressional Budget Office Analysis of HR971 Rejects Pharmacy Benefit Managers' Bogus Claim Bill Would Cost $29 Billion Over 5 Years
Date:1/16/2008

CBO Estimates Bill Allowing Pharmacies to Negotiate Collectively Would Increase Costs by Only $727 million over Ten Years

WASHINGTON, Jan. 16 /PRNewswire-USNewswire/ -- Despite pharmacy benefit managers' (PBMs) claims that HR971, the bill allowing independent pharmacies to collectively negotiate with PBMs, would increase costs to Medicare D and private drug insurers by $29 billion, the Congressional Budget Office (CBO) rejected this bogus number.

This month CBO found that HR971 would increase costs to Medicare D, Medicaid, and the Federal Employees Health Benefits (FEHB) program by $727 million over ten years. This is less than 3% of the unfounded $29 billion that the Pharmaceutical Care Management Association (PCMA), which represents PBMs, claims the bill would cost Medicare D and other payers over five years. The Association of Community Pharmacists Congressional Network (ACP*CN) hopes this CBO report will encourage members of Congress to swiftly pass HR971 and the Senate companion bill S2161.

"Pharmacy benefit managers' repeated attempts to distort market place realities and the way they conduct business with independent pharmacies is once again exposed in this CBO report. The CBO estimate is a real workable number compared to the PBMs outlandish, make believe figure. All along we have said that PBMs use their monopolistic standing in the marketplace to routinely misrepresent the facts and under-reimburse neighborhood pharmacies for Medicare D drugs," said Mike James, Vice-President, Government Affairs, ACP*CN.

"The recent OIG report underscores this reality, concluding that PBM reimbursements to community pharmacists were only 17.3% to 18.1% above our acquisition costs. This is well below the established 20-21% overhead costs needed to operate a pharmacy, which means we are losing money on every Medicare prescription. The time is now for Congress to grant independent pharmacies an exemption in the nation's anti-trust
'/>"/>

SOURCE Association of Community Pharmacists Congressional Network
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Congressional Budget Includes Earmark to Keep Washingtons Sexual Assault DNA Program Moving Forward
2. Statement by American Heart Association Immediate-Past President Raymond Gibbons, M.D. on Congressional Omnibus Spending Bill
3. NCPA Applauds Pharmacy TRICARE Provisions in the Congressional Passage of the Defense Authorization Bill
4. Lung Cancer Alliance Praises Congressional Call for Increased Commitment to Fund Lung Cancer Research
5. National physician organization supports Capps-Rogers Bill at todays congressional briefing
6. Congressional failure to override SCHIP veto saddens physicians
7. American Heart Association Congratulates Pioneer Heart Surgeon for Being Named Recipient of Congressional Gold Medal Award
8. Capps to Lead Bipartisan Womens Caucus Congressional Delegation to Represent United States at Women Deliver Conference in London
9. Congressional Support Grows for FDA Regulation of Tobacco: Bill Now Sponsored by 55 Senators, 200 Representatives
10. AGD Applauds Congressional Support of SCHIP Reauthorization
11. More than 125 State Leaders - Including Governor, Lt. Governor, and Congressional Delegation - Endorse Campaign to Make Delawares Kids the Healthiest in the Nation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... no secret that millions of Americans are struggling with ... Abuse, nearly 24 million Americans are using some form ... fact that the total number of users has increased ... struggle with substance abuse often feel there may never ... has released updated lists of substance abuse resources ...
(Date:8/20/2014)... 2014 A Missouri federal judge has remanded ... were treated with GranuFlo and NaturaLyte to the City of ... Baron and Budd. The judge rejected an assertion by the ... were invalid. (McGee, et al. v. Fresenius Medical Care North ... Medical Care, is the manufacturer of the dialysis products GranuFlo ...
(Date:8/20/2014)... -- Taking the widely used antibiotic clarithromycin ... causes, a new study suggests. Because millions of ... urgent confirmation, said the Danish researchers behind the study. ... and that guidelines for the use of the drug ... One heart expert wasn,t surprised by the finding, ...
(Date:8/20/2014)... Chemically extracted acellular allogeneic nerve, from which ... have been removed, reduced postoperative immune rejection. ... neural substrates and base materials, such as ... can provide a good scaffold in the ... allogeneic nerve, similar to autologous nerve transplantation, ...
(Date:8/20/2014)... Angeles, CA (PRWEB) August 20, 2014 If ... has found a cure for it. With extensive research on ... provider named ‘MetroMD’ claims to have perfected the art of ... you a brand new younger look with their revolutionary anti-aging ... secrets of the 21st century fountain of youth, the MD ...
Breaking Medicine News(10 mins):Health News:Re-Launched AbuseTreatmentCenters.net Offering New List of Substance Abuse Resources 2Health News:GranuFlo/NaturaLyte Case Remanded to State Court By Missouri Federal Judge, Baron and Budd Reports 2Health News:Antibiotic Might Raise Heart Risks for Some 2Health News:MetroMD Offers Revolutionary Anti-aging Hormone Therapy in Hollywood Area 2
... may indicate underlying disease, study finds , , FRIDAY, Aug. 8 ... play a pivotal role in increasing an older American,s risk ... a new report says. , Levels of adiponectin increase in ... the cardiovascular health of older people, according to the new ...
... Alaska The University of Alaska Fairbanks campus will be ... 12-14, 2008. , The biennial conference is organized in ... Arctic Region and brings together international participants to address ... host to the 2008 conference. , More than150 guests ...
... Delivers Cheer, Medication and Equipment to Young Patients and Helps ... Raise Money for Make-A-Wish ... general,availability of its train-themed "JR" autonomous mobile robot to children,s,hospitals ... the,national Make-A-Wish Foundation for each JR TUG that is deployed. ...
... 1-inch cut behind uterus and into woman,s body cavity ... they say may be the first operation of its ... Hospital/Columbia University Medical Center removed a woman,s gallbladder without ... as part of an ongoing clinical research trial, involved ...
... EDT, Thursday, ... August 14, PRINCETON, ... advanced wound care products,announced plans to release its second quarter 2008 results ... the Company will,hold a conference call that same day to discuss the ...
... Inc. (NYSE: HGR ) is pleased to ... Hanger Orthopedic Group, Inc. to "positive",from "stable." Moody,s ... "We are pleased with the outlook change ... the last ten quarters," remarked George McHenry,Hanger,s Chief ...
Cached Medicine News:Health News:Fat Cell Protein Boosts Heart Attack Risk in Elderly 2Health News:UAF to host Eighth Conference of Arctic Parliamentarians 2Health News:Charlotte Children's Hospital Gets a Delivery from Aethon's Train-Themed Robot This Fall 2Health News:Charlotte Children's Hospital Gets a Delivery from Aethon's Train-Themed Robot This Fall 3Health News:New Technique Removes Gallbladder Without External Incisions 2Health News:Derma Sciences Conference Call Advisory 2
(Date:8/20/2014)... , Aug. 20, 2014  Glades Drugs, an independent ... is proud to announce its expansion into a new corporate ... will feature an 8,000-square-foot office space and state of the ... applications for 100 open positions for the new facility. ... Lantana Road will serve as the chain,s corporate headquarters and ...
(Date:8/20/2014)... Reportlinker.com announces that a new market research report ... Patient Scales Industry http://www.reportlinker.com/p01374301/Global-Patient-Scales-Industry.html ... markets for Patient Scales in US$ Thousand by ... Baby Scales, Chair Scales, and Under Bed Scales. ... US, Canada, Japan, Europe, Asia-Pacific, Latin America, and ...
(Date:8/20/2014)... 2014 Phase I Trial of ... KalVista Pharmaceuticals ("KalVista"), an ophthalmology company with ... that it has begun a Phase I, First in ... for the treatment of DME. The study,s Principal Investigator ... Institute, Joslin Diabetes Center; Harvard Medical School Department of ...
Breaking Medicine Technology:Glades Drugs Moves to New Corporate Headquarters, 100 Open Positions 2Global Patient Scales Industry 2Global Patient Scales Industry 3Global Patient Scales Industry 4Global Patient Scales Industry 5Global Patient Scales Industry 6Global Patient Scales Industry 7Global Patient Scales Industry 8Global Patient Scales Industry 9Global Patient Scales Industry 10Global Patient Scales Industry 11Global Patient Scales Industry 12Global Patient Scales Industry 13Global Patient Scales Industry 14Global Patient Scales Industry 15Global Patient Scales Industry 16Global Patient Scales Industry 17Global Patient Scales Industry 18Global Patient Scales Industry 19KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema 2KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema 3KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema 4
... Medical ® today announced that it has closed on ... by Singapore-based Crescent Point Group, with existing investors, Maverick ... Ventures and Affinity Capital, making additional investments. Sami Sindi, ... board of directors. Moelis & Company acted as financial ...
... Jan. 9, 2012  MolecularHealth, a clinico-molecular informatics company, ... two next generation product lines that translate patient-specific ... scientific evidence into safer, more effective drug choices ... producing genomic information falling drastically and clinical data ...
Cached Medicine Technology:Uptake Medical Announces Successful Completion of Series C Financing 2MolecularHealth to Introduce Knowledge-Driven Solutions that Enhance Drug Safety and Enable Molecularly-Guided Treatment Decision Support 2MolecularHealth to Introduce Knowledge-Driven Solutions that Enhance Drug Safety and Enable Molecularly-Guided Treatment Decision Support 3
... CMIS Telemetry System is a telemetry ... hospitals which require monitoring and performance. ... are able to monitor patients from ... transmitters and wireless bedsides. Now, monitoring ...
... Telemetry System, portable TeleMon companion monitor, ... integrated surveillance and monitoring solution for ... of ECG and SpO2. Clinicians can ... patient information from the central station, ...
TeleRehab Advantage is a monitoring system that automates the generation of outcomes data. Patient information and session information is automatically transferred from the monitoring program to Outc...
ISI DuraHand is the reusable, easy to sterilize surgical hand immobilizer....
Medicine Products: